Heterozygous PDGFRB Mutation in a Three-generation Family with Autosomal Dominant Infantile Myofibromatosis.

1https://www.medicaljournals.se/acta/content/abstract/10.2340/00015555-2671 Infantile myofibromatosis (IM; MIM#228550) is a rare disorder of myofibroblastic proliferation and is one of the most common causes of benign fibrous tumour of infancy (1). IM is categorized into solitary, multicentric and generalized forms, with solitary IM being the most common. While solitary IM is characterized by the presence of a single cutaneous nodule, multicentric IM involves the skin, subcutaneous tissues, muscles and bones. Both forms of IM regress spontaneously during childhood. Generalized IM is characterized by visceral involvement, and may have a poor outcome. Although IM is mainly sporadic, 30 families suggestive of autosomal dominant (AD) or autosomal recessive (AR) inheritance have been reported. Recently, heterozygous mutations in PDGFRB and NOTCH3 have been reported in 13 families with AD IM (2, 3). We report here, a 3-generation family with multicentric AD IM and a novel PDGFRB mutation (c.1679C>T; p.P560L).

[1]  W. Chung,et al.  A recurrent PDGFRB mutation causes familial infantile myofibromatosis. , 2013, American journal of human genetics.

[2]  C. Pecquet,et al.  PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib , 2016, Oncogene.

[3]  Julie C. Sapp,et al.  A Point Mutation in PDGFRB Causes Autosomal-Dominant Penttinen Syndrome. , 2015, American journal of human genetics.

[4]  H. Okano,et al.  Novel overgrowth syndrome phenotype due to recurrent de novo PDGFRB mutation. , 2015, The Journal of pediatrics.

[5]  R. G. C. C. L. Cardenas,et al.  Modulation of expressivity in PDGFRB-related infantile myofibromatosis: a role for PTPRG? , 2014, Genetics and molecular research : GMR.

[6]  L. Defebvre,et al.  Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification , 2013, Neurology.

[7]  Wen Hwa Lee,et al.  Large-Scale Structural Analysis of the Classical Human Protein Tyrosine Phosphatome , 2009, Cell.

[8]  Yiran Guo,et al.  Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis. , 2013, American journal of human genetics.

[9]  Fredrik Lanner,et al.  Notch Signaling Regulates Platelet-Derived Growth Factor Receptor-β Expression in Vascular Smooth Muscle Cells , 2008, Circulation research.

[10]  Christine Bodemer,et al.  Infantile myofibromatosis: a series of 28 cases. , 2014, Journal of the American Academy of Dermatology.

[11]  C. Heldin,et al.  Targeting the PDGF signaling pathway in tumor treatment , 2013, Cell Communication and Signaling.